Quick Takeaways
- Invus Global Management, LLC filed SCHEDULE 13G/A for enGene Therapeutics Inc. Common Shares (ENGN).
- Disclosed ownership: 7.8%.
- Date of event: 31 Mar 2026.
Invus Global Management, LLC - 31 Mar 2026 SCHEDULE 13G/A Report for enGene Therapeutics Inc. Common Shares (ENGN)
- Filing Manager
- Invus Global Management, LLC
- Reporting Manager
- Raymond Debbane
- Symbol
- ENGN
- Shares outstanding
- 67,348,192 shares
- Disclosed Ownership
- 5,253,159 shares
- Ownership
- 7.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 May 2026, 10:59:23 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 27 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Invus Global Management, LLC disclosed 7.8% ownership in enGene Therapeutics Inc. Common Shares (ENGN) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 27 Jan 2026.
- Current filing was accepted on 05 May 2026, 10:59.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (8)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 6.7% | 4,513,228 | 4,513,228 | 0 | /s/ Raymond Debbane | Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner | |
| Invus Public Equities Advisors, LLC | 6.7% | 4,513,228 | 4,513,228 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Invus Global Management, LLC | 6.7% | 4,513,228 | 4,513,228 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Siren, L.L.C. | 6.7% | 4,513,228 | 4,513,228 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Avicenna Life Sci Master Fund LP | 1.1% | 739,931 | 739,931 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner | |
| Avicenna Life Sci Master GP LLC | 1.1% | 739,931 | 739,931 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer | |
| Ulys, L.L.C. | 1.1% | 739,931 | 739,931 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Raymond Debbane | 7.8% | 5,253,159 | 5,253,159 | 0 | /s/ Raymond Debbane | Raymond Debbane |